Author: Healthcare Propulsion Staff

A Rutgers-led international collaboration has identified 36 genes that substantially raise the risk for obsessive-compulsive disorder (OCD) and chronic tic disorders – providing what two researchers said is the most detailed biological understanding of how these conditions develop – and how they might eventually be treated. Before this study, published in Nature Neuroscience, scientists had found a few genetic clues, each linked separately to OCD or chronic tic disorders. Gary Heiman, a professor in the Department of Genetics in the Rutgers School of Arts and Sciences and a senior coauthor of the study, said the research “dramatically expands the catalog…

The iron shield boss was covered with caked earth when it was found.(Image credit: Bartłomiej Bartecki, Hrubieszów Museum)A man searching for spare auto parts at a junkyard in Poland discovered an entirely different kind of treasure: part of a 1,800-year-old shield that was filled with bones.The shield’s age and location suggest that it belonged to a Vandal warrior, according to the archaeologists who excavated the find. The Vandals were Germanic people who lived in Poland at that time. After the Germanic invasions of the Roman Empire, the Vandals, whose name became synonymous with destruction, moved south and eventually settled in…

Immediate coronary angiography did not improve 30-day survival compared with a deferred strategy in patients without an ECG ST-elevation after out-of-hospital cardiac arrest. These were the main findings of the DISCO trial and a meta-analysis presented in a Hot Line session today at ESC Congress 2026. Acute coronary syndrome is a common cause of out-of-hospital cardiac arrest (OHCA). In patients with OHCA presenting with an ST-elevation on an ECG, immediate coronary angiography to assess artery blockages is recommended, with subsequent percutaneous coronary intervention (PCI) where necessary to restore blood flow. However, evidence for the use of coronary angiography in patients…

BeOne Medicines, Ltd., a global oncology company, today announced a voluntary agreement with the U.S. Government to expand access to innovative cancer medicines for American patients while strengthening our U.S manufacturing footprint and further expanding the capabilities needed to deliver medicines at scale. The agreement builds on BeOne’s longstanding commitment to patient access and investment in research and scientific innovation. At BeOne, we believe every patient should benefit from innovative cancer therapies. We appreciate the Trump Administration’s commitment to advancing solutions that broaden access and scientific progress for American patients. This agreement reflects our purpose to reach more patients as…

UZH researchers have developed a novel therapy for multiple sclerosis that is designed to stop the misguided immune response without suppressing the immune system as a whole. An initial clinical trial shows that the approach is safe and well tolerated. In addition, the demonstrated mechanisms of action are highly promising. The principle could also be applied for treating other autoimmune diseases. Multiple sclerosis (MS) is a chronic inflammatory autoimmune disease that particularly affects young adults. The disease is driven by immune cells – primarily what are known as T lymphocytes. These cells normally fight off pathogens such as viruses, bacteria…

A therapeutic approach pioneered in Mainz for the treatment of multiple sclerosis (MS) is taking an important step toward clinical application. The team led by Professor Claire Jacob at Johannes Gutenberg University Mainz (JGU) is further developing a drug patch that could promote the repair of damaged myelin sheaths. ForTra gGmbH for Research Transfer (ForTra), a subsidiary of the Else Kröner-Fresenius Foundation, is supporting the project with EUR 1.1 million. The aim is to further develop the patch for production according to pharmaceutical quality standards and subsequently assess its safety and tolerability in an initial clinical trial. Prototypes of transdermal…

Fresh off the Glasgow 2026 Commonwealth Games, Hong Kong-born Tammy Wong is still buzzing – and not just from the adrenaline.The 30-year-old weightlifter, who represented England in the women’s 48kg category, finished with a combined total of 160kg (352lbs), just 7kg shy of a podium finish, and five off her own personal best.A three-time champion of British Weight Lifting’s British Championships, Wong played hockey as a child, continuing through university while going to the gym on the side. During the Covid-19 pandemic, she watched women doing CrossFit and weightlifting and thought to herself: “Oh my God – these women are…

Children whose appendix has burst often develop serious abdominal infections that are hard to treat and increasingly resistant to antibiotics. In a recent study, researchers tested whether a light-activated blue dye, activated by a laser inside the abdomen during minimally invasive surgery, could safely kill those bacteria. Timothy M. Baran, PhD & Korry T. Wirth, MD, MS. Image Credit: American Society for Laser Medicine and Surgery, Inc. The preclinical study led by Nicole A. Wilson, MD, PhD, FACS; Timothy M. Baran, PhD; and Korry T. Wirth, MD, MS, is titled, “Laparoscopic Methylene Blue Photodynamic Therapy for Intraabdominal Infection: A Preclinical…

The ZWO Seestar S50 Pro was released on Aug. 25, 2026. It’s a smart telescope that ships with everything you need to get started with astronomy and solar observations, eliminating the need to buy any other accessories.It is controlled through the Seestar app on a smartphone and offers automatic slewing and autofocused views of galaxies, nebulas, star clusters and more. That said, in our experience, it sometimes needs manual adjustment with the on-screen joystick to perfect centering.This being the Pro version of the original S50, which released three years prior, it’s more expensive; you’ll be paying $450 more than the…

Yellow fever is appearing in regions that haven’t seen cases of the disease in years, largely as a result of climate change.Historically, the virus ravaged cities across the Americas, Europe and Africa, until a vaccine was introduced in 1937 and its range shrunk significantly. But now, as climate change creates favorable conditions for virus-carrying mosquitoes, scientists are seeing outbreaks in unexpected areas.”Yellow fever is a highly deadly disease,” Dr. Joelle Ivy Rosser, an infectious-disease researcher at Stanford University, told Live Science, “so any environmental pressures that increase the likelihood of future yellow fever virus outbreaks … is highly concerning.”How is…